Brain Monitoring Market by Technology(Devices and Accessories),and Application(Epilepsy, Dementia, Parkinsons Disease, Huntingtons Disease, Headache Disorders, Stroke, Traumatic Brain Injuries and Sleep Disorders)-Global Opportunity Analysis and Industry Forecast, 2018-2025
Brain monitoring is the process of identifying any abnormality in the functioning of the brain cells by exploring the structure and function of the brain. These are used to monitor neurological disorders such as Alzheimer’s, Parkinson’s, epilepsy, dementia, multiple sclerosis, sleep disorder, brain tumor, and others. The process involves the use of several brain monitoring devices to track brain functions such as the velocity of blood flow in the veins and arteries in the case of epilepsy and traumatic brain injury. The global brain monitoring market generated $3,850 million in 2017, and is projected to reach $6,595 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025.
The global brain monitoring market is expected to register substantial growth in the near future, owing to the increase in the geriatric population and rise in prevalence of neurological disorders. In addition, technological advancements are expected to boost the market growth during the forecast period. However, stringent government regulations and unfavorable reimbursement policies are expected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries is expected to offer remunerative opportunities for the market players. The impact of the driving factors is expected to surpass that of the restraints.
The global brain monitoring market is segmented into product type, procedure, application, and region. By product, the market is categorized into electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices, electromyography (EMG) devices, and accessories. The accessories segmented in further classified into electrodes, sensors, pastes & gels, caps, cables, batteries, and others. Based on procedure, market is bifurcated invasive and non-invasive. Based on application, it is categorized into epilepsy, dementia, Parkinson’s disease, Huntington's disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report highlights the market dynamics to understand the global brain monitoring market and capitalize on the prevailing opportunities.
Quantitative analysis of the current market and forecasts would assist stakeholders to design business strategies accordingly.
Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
KEY MARKET SEGMENTS
By Product Type
The global brain monitoring market is expected to register substantial growth in the near future, owing to the increase in the geriatric population and rise in prevalence of neurological disorders. In addition, technological advancements are expected to boost the market growth during the forecast period. However, stringent government regulations and unfavorable reimbursement policies are expected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries is expected to offer remunerative opportunities for the market players. The impact of the driving factors is expected to surpass that of the restraints.
The global brain monitoring market is segmented into product type, procedure, application, and region. By product, the market is categorized into electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices, electromyography (EMG) devices, and accessories. The accessories segmented in further classified into electrodes, sensors, pastes & gels, caps, cables, batteries, and others. Based on procedure, market is bifurcated invasive and non-invasive. Based on application, it is categorized into epilepsy, dementia, Parkinson’s disease, Huntington's disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report highlights the market dynamics to understand the global brain monitoring market and capitalize on the prevailing opportunities.
Quantitative analysis of the current market and forecasts would assist stakeholders to design business strategies accordingly.
Porter's five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.
KEY MARKET SEGMENTS
By Product Type
- Electroencephalography (EEG) Devices
- Magnetoencephalography (MEG) Devices
- Transcranial Doppler (TCD) Devices
- Intracranial Pressure (ICP) Monitors
- Cerebral Oximeters
- Magnetic Resonance Imaging (MRI) Devices
- Computerized Tomography (CT) Devices
- Positron Emission Tomography (PET) Devices
- Sleep Monitoring Devices
- Electromyography (EMG) Devices
- Accessories
- Electrodes
- Sensors
- Pastes and Gels
- Caps
- Cables
- Batteries
- Others
- By Procedure
- Invasive
- Non-invasive
- Epilepsy
- Dementia
- Parkinson's Disease
- Huntington's Disease
- Headache Disorders
- Stroke
- Traumatic Brain Injuries
- Sleep Disorders
- Other Diseases
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Spain
- Italy
- UK
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Advanced Brain Monitoring, Inc.
- CAS Medical Systems, Inc.
- Compumedics Ltd.
- General Electric Company (GE Healthcare)
- Koninklijke Philips N.V. (Philips Healthcare)
- Medtronic Plc.
- Natus Medical Incorporated
- Neural Analytics, Inc.
- Siemens AG
- Cadwell Laboratories
- Neurosoft Limited
- Elekta A.B.
- InfraSacn, Inc.
- BrainScope Company, Inc.
CHAPTER: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the geriatric population
3.4.1.2. Increase in prevalence of neurological disorders
3.4.1.3. Technological advancements
3.4.2. Restraints
3.4.2.1. Stringent government regulations
3.4.2.2. Unfavorable reimbursement policies
3.4.3. Opportunity
3.4.3.1. Untapped markets in developing countries
CHAPTER: 4: BRAIN MONITORING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Electroencephalography devices (EEG)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Magnetoencephalography devices (MEG)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Transcranial Doppler devices (TCD)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Intracranial pressure monitors (ICP)
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Cerebral oximeters
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Electromyography devices
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Magnetic resonance imaging devices (MRI)
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Computerized tomography devices (CT)
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
4.10. Positron emission tomography devices (PET)
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast
4.10.3. Market analysis, by country
4.11. Sleep monitoring devices
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast
4.11.3. Market analysis, by country
4.12. Accessories
4.12.1. Key market trends, growth factors, and opportunities
4.12.1.1. Electrodes
4.12.1.2. Sensors
4.12.1.3. Paste & Gels
4.12.1.4. Caps
4.12.1.5. Cables
4.12.1.6. Batteries
4.12.1.7. Others
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country
4.13. Other brain monitoring devices
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast
4.13.3. Market analysis, by country
CHAPTER: 5: BRAIN MONITORING MARKET, BY PROCEDURE
5.1. Overview
5.1.1. Market size and forecast
5.2. Invasive
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Non-invasive
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER: 6: BRAIN MONITORING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Epilepsy
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Dementia
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Parkinson’s Disease
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Huntington's Disease
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Headache Disorders
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
6.7. Stroke
6.7.1. Market size and forecast
6.7.2. Market analysis, by country
6.8. Traumatic Brain Injuries
6.8.1. Market size and forecast
6.8.2. Market analysis, by country
6.9. Sleep Disorders
6.9.1. Market size and forecast
6.9.2. Market analysis, by country
6.10. Other Diseases
6.10.1. Market size and forecast
6.10.2. Market analysis, by country
CHAPTER: 7: BRAIN MONITORING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product type
7.2.3. Market size and forecast, by procedure
7.2.4. Market size and forecast, by application
7.2.5. North America market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by product type
7.2.5.2. U.S. market size and forecast, by procedure
7.2.5.3. U.S. market size and forecast, by application
7.2.5.4. Canada market size and forecast, by product type
7.2.5.5. Canada market size and forecast, by procedure
7.2.5.6. Canada market size and forecast, by application
7.2.5.7. Mexico market size and forecast, by product type
7.2.5.8. Mexico market size and forecast, by procedure
7.2.5.9. Mexico market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by product type
7.3.3. Market size and forecast, by procedure
7.3.4. Market size and forecast, by application
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by procedure
7.3.5.3. Germany market size and forecast, by application
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by procedure
7.3.5.6. France market size and forecast, by application
7.3.5.7. UK market size and forecast, by product type
7.3.5.8. UK market size and forecast, by procedure
7.3.5.9. UK market size and forecast, by application
7.3.5.10. Italy market size and forecast, by product type
7.3.5.11. Italy market size and forecast, by procedure
7.3.5.12. Italy market size and forecast, by application
7.3.5.13. Spain market size and forecast, by product type
7.3.5.14. Spain market size and forecast, by procedure
7.3.5.15. Spain market size and forecast, by application
7.3.5.16. Rest of Europe market size and forecast, by product type
7.3.5.17. Rest of Europe market size and forecast, by procedure
7.3.5.18. Rest of Europe market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by product type
7.4.3. Market size and forecast, by procedure
7.4.4. Market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by procedure
7.4.5.3. Japan market size and forecast, by application
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by procedure
7.4.5.6. China market size and forecast, by application
7.4.5.7. Australia market size and forecast, by product type
7.4.5.8. Australia market size and forecast, by procedure
7.4.5.9. Australia market size and forecast, by application
7.4.5.10. India market size and forecast, by product type
7.4.5.11. India market size and forecast, by procedure
7.4.5.12. India market size and forecast, by application
7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.14. Rest of Asia-Pacific market size and forecast, by procedure
7.4.5.15. Rest of Asia-Pacific market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by product type
7.5.3. Market size and forecast, by procedure
7.5.4. Market size and forecast, by application
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by procedure
7.5.5.3. Brazil market size and forecast, by application
7.5.5.4. Saudi Arabia market size and forecast, by product type
7.5.5.5. Saudi Arabia market size and forecast, by procedure
7.5.5.6. Saudi Arabia market size and forecast, by application
7.5.5.7. South Africa market size and forecast, by product type
7.5.5.8. South Africa market size and forecast, by procedure
7.5.5.9. South Africa market size and forecast, by application
7.5.5.10. Rest of LAMEA market size and forecast, by product type
7.5.5.11. Rest of LAMEA market size and forecast, by procedure
7.5.5.12. Rest of LAMEA market size and forecast, by application
CHAPTER: 8: COMPANY PROFILES
8.1. ADVANCED BRAIN MONITORING, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. CAS MEDICAL SYSTEMS, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Business performance
8.3. COMPUMEDICS LTD.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product Portfolio
8.3.5. Business performance
8.4. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. NATUS MEDICAL INCORPORATED
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. NEURAL ANALYTICS, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NIHON KOHDEN CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. SIEMENS AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the geriatric population
3.4.1.2. Increase in prevalence of neurological disorders
3.4.1.3. Technological advancements
3.4.2. Restraints
3.4.2.1. Stringent government regulations
3.4.2.2. Unfavorable reimbursement policies
3.4.3. Opportunity
3.4.3.1. Untapped markets in developing countries
CHAPTER: 4: BRAIN MONITORING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Electroencephalography devices (EEG)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Magnetoencephalography devices (MEG)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Transcranial Doppler devices (TCD)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Intracranial pressure monitors (ICP)
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Cerebral oximeters
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Electromyography devices
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Magnetic resonance imaging devices (MRI)
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Computerized tomography devices (CT)
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
4.10. Positron emission tomography devices (PET)
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast
4.10.3. Market analysis, by country
4.11. Sleep monitoring devices
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast
4.11.3. Market analysis, by country
4.12. Accessories
4.12.1. Key market trends, growth factors, and opportunities
4.12.1.1. Electrodes
4.12.1.2. Sensors
4.12.1.3. Paste & Gels
4.12.1.4. Caps
4.12.1.5. Cables
4.12.1.6. Batteries
4.12.1.7. Others
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country
4.13. Other brain monitoring devices
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast
4.13.3. Market analysis, by country
CHAPTER: 5: BRAIN MONITORING MARKET, BY PROCEDURE
5.1. Overview
5.1.1. Market size and forecast
5.2. Invasive
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Non-invasive
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER: 6: BRAIN MONITORING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Epilepsy
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Dementia
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Parkinson’s Disease
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Huntington's Disease
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Headache Disorders
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
6.7. Stroke
6.7.1. Market size and forecast
6.7.2. Market analysis, by country
6.8. Traumatic Brain Injuries
6.8.1. Market size and forecast
6.8.2. Market analysis, by country
6.9. Sleep Disorders
6.9.1. Market size and forecast
6.9.2. Market analysis, by country
6.10. Other Diseases
6.10.1. Market size and forecast
6.10.2. Market analysis, by country
CHAPTER: 7: BRAIN MONITORING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product type
7.2.3. Market size and forecast, by procedure
7.2.4. Market size and forecast, by application
7.2.5. North America market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by product type
7.2.5.2. U.S. market size and forecast, by procedure
7.2.5.3. U.S. market size and forecast, by application
7.2.5.4. Canada market size and forecast, by product type
7.2.5.5. Canada market size and forecast, by procedure
7.2.5.6. Canada market size and forecast, by application
7.2.5.7. Mexico market size and forecast, by product type
7.2.5.8. Mexico market size and forecast, by procedure
7.2.5.9. Mexico market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by product type
7.3.3. Market size and forecast, by procedure
7.3.4. Market size and forecast, by application
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by procedure
7.3.5.3. Germany market size and forecast, by application
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by procedure
7.3.5.6. France market size and forecast, by application
7.3.5.7. UK market size and forecast, by product type
7.3.5.8. UK market size and forecast, by procedure
7.3.5.9. UK market size and forecast, by application
7.3.5.10. Italy market size and forecast, by product type
7.3.5.11. Italy market size and forecast, by procedure
7.3.5.12. Italy market size and forecast, by application
7.3.5.13. Spain market size and forecast, by product type
7.3.5.14. Spain market size and forecast, by procedure
7.3.5.15. Spain market size and forecast, by application
7.3.5.16. Rest of Europe market size and forecast, by product type
7.3.5.17. Rest of Europe market size and forecast, by procedure
7.3.5.18. Rest of Europe market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by product type
7.4.3. Market size and forecast, by procedure
7.4.4. Market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by procedure
7.4.5.3. Japan market size and forecast, by application
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by procedure
7.4.5.6. China market size and forecast, by application
7.4.5.7. Australia market size and forecast, by product type
7.4.5.8. Australia market size and forecast, by procedure
7.4.5.9. Australia market size and forecast, by application
7.4.5.10. India market size and forecast, by product type
7.4.5.11. India market size and forecast, by procedure
7.4.5.12. India market size and forecast, by application
7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.14. Rest of Asia-Pacific market size and forecast, by procedure
7.4.5.15. Rest of Asia-Pacific market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by product type
7.5.3. Market size and forecast, by procedure
7.5.4. Market size and forecast, by application
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by procedure
7.5.5.3. Brazil market size and forecast, by application
7.5.5.4. Saudi Arabia market size and forecast, by product type
7.5.5.5. Saudi Arabia market size and forecast, by procedure
7.5.5.6. Saudi Arabia market size and forecast, by application
7.5.5.7. South Africa market size and forecast, by product type
7.5.5.8. South Africa market size and forecast, by procedure
7.5.5.9. South Africa market size and forecast, by application
7.5.5.10. Rest of LAMEA market size and forecast, by product type
7.5.5.11. Rest of LAMEA market size and forecast, by procedure
7.5.5.12. Rest of LAMEA market size and forecast, by application
CHAPTER: 8: COMPANY PROFILES
8.1. ADVANCED BRAIN MONITORING, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. CAS MEDICAL SYSTEMS, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Business performance
8.3. COMPUMEDICS LTD.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product Portfolio
8.3.5. Business performance
8.4. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. NATUS MEDICAL INCORPORATED
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. NEURAL ANALYTICS, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NIHON KOHDEN CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. SIEMENS AG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 02. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 03. BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 04. BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 05. BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY REGION, 2017–2025 ($MILLION)
TABLE 06. BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY REGION, 2017–2025 ($MILLION)
TABLE 07. BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 08. BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 09. BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 10. BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 11. BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 12. BRAIN MONITORING MARKET FOR ACCESSORIES, BY REGION, 2017–2025 ($MILLION)
TABLE 13. BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 14. GLOBAL BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 15. BRAIN MONITORING MARKET FOR INVASIVE, BY REGION, 2017–2025 ($MILLION)
TABLE 16. BRAIN MONITORING MARKET FOR NON-INVASIVE, BY REGION, 2017–2025 ($MILLION)
TABLE 17. GLOBAL BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 18. BRAIN MONITORING MARKET FOR EPILEPSY, BY REGION, 2017–2025 ($MILLION)
TABLE 19. BRAIN MONITORING MARKET FOR DEMENTIA, BY REGION, 2017–2025 ($MILLION)
TABLE 20. BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY REGION, 2017–2025 ($MILLION)
TABLE 21. BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY REGION, 2017–2025 ($MILLION)
TABLE 22. BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY REGION, 2017–2025 ($MILLION)
TABLE 23. BRAIN MONITORING MARKET FOR STROKE, BY REGION, 2017–2025 ($MILLION)
TABLE 24. BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY REGION, 2017–2025 ($MILLION)
TABLE 25. BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2017–2025 ($MILLION)
TABLE 26. BRAIN MONITORING MARKET FOR OTHER DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 27. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 28. NORTH AMERICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 29. NORTH AMERICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 30. NORTH AMERICA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 31. NORTH AMERICA BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 32. U.S. BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 33. U.S. BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 34. U.S. BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 35. CANADA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 36. CANADA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 37. CANADA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 38. MEXICO BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 39. MEXICO BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 40. MEXICO BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 41. EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 42. EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 43. EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 44. EUROPE BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 45. GERMANY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 46. GERMANY BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 47. GERMANY BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 48. FRANCE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 49. FRANCE BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 50. FRANCE BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 51. UK BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 52. UK BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 53. UK BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 54. ITALY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55. ITALY BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 56. ITALY BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 57. SPAIN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 58. SPAIN BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 59. SPAIN BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 60. REST OF EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 61. REST OF EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 62. REST OF EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 63. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 65. ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 66. ASIA-PACIFIC BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 67. JAPAN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 68. JAPAN BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 69. JAPAN BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 70. CHINA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 71. CHINA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 72. CHINA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 73. AUSTRALIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 74. AUSTRALIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 75. AUSTRALIA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 76. INDIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 77. INDIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 78. INDIA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 82. LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 83. LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 84. LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 85. LAMEA BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 86. BRAZIL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 87. BRAZIL BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 88. BRAZIL BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 89. SAUDI ARABIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 90. SAUDI ARABIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 91. SAUDI ARABIA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 92. SOUTH AFRICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 93. SOUTH AFRICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 94. SOUTH AFRICA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 95. REST OF LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 96. REST OF LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 97. REST OF LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 98. ADVANCED BRAIN MONITORING: COMPANY SNAPSHOT
TABLE 99. ADVANCED BRAIN MONITORING: BUSINESS AREA
TABLE 100. ADVANCED BRAIN MONITORING: PRODUCT PORTFOLIO
TABLE 101. CASMED: COMPANY SNAPSHOT
TABLE 102. CASMED: PRODUCT PORTFOLIO
TABLE 103. COMPUMEDICS: COMPANY SNAPSHOT
TABLE 104. COMPUMEDICS: PRODUCT PORTFOLIO
TABLE 105. GE: COMPANY SNAPSHOT
TABLE 106. GE: OPERATING SEGMENTS
TABLE 107. GE: PRODUCT PORTFOLIO
TABLE 108. PHILIPS: COMPANY SNAPSHOT
TABLE 109. PHILIPS: OPERATING SEGMENTS
TABLE 110. PHILIPS: PRODUCT PORTFOLIO
TABLE 111. MEDTRONIC: COMPANY SNAPSHOT
TABLE 112. MEDTRONIC: OPERATING SEGMENTS
TABLE 113. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 114. NATUS: COMPANY SNAPSHOT
TABLE 115. NATUS: PRODUCT PORTFOLIO
TABLE 116. NEURAL ANALYTICS: COMPANY SNAPSHOT
TABLE 117. NEURAL ANALYTICS: PRODUCT PORTFOLIO
TABLE 118. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 119. GSK: PRODUCT PORTFOLIO
TABLE 120. SEIMENS: COMPANY SNAPSHOT
TABLE 121. SEIMENS: PRODUCT SEGMENTS
TABLE 122. SEIMENS: PRODUCT PORTFOLIO
TABLE 01. GLOBAL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 02. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 03. BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 04. BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 05. BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY REGION, 2017–2025 ($MILLION)
TABLE 06. BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY REGION, 2017–2025 ($MILLION)
TABLE 07. BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 08. BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 09. BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 10. BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 11. BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 12. BRAIN MONITORING MARKET FOR ACCESSORIES, BY REGION, 2017–2025 ($MILLION)
TABLE 13. BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 14. GLOBAL BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 15. BRAIN MONITORING MARKET FOR INVASIVE, BY REGION, 2017–2025 ($MILLION)
TABLE 16. BRAIN MONITORING MARKET FOR NON-INVASIVE, BY REGION, 2017–2025 ($MILLION)
TABLE 17. GLOBAL BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 18. BRAIN MONITORING MARKET FOR EPILEPSY, BY REGION, 2017–2025 ($MILLION)
TABLE 19. BRAIN MONITORING MARKET FOR DEMENTIA, BY REGION, 2017–2025 ($MILLION)
TABLE 20. BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY REGION, 2017–2025 ($MILLION)
TABLE 21. BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY REGION, 2017–2025 ($MILLION)
TABLE 22. BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY REGION, 2017–2025 ($MILLION)
TABLE 23. BRAIN MONITORING MARKET FOR STROKE, BY REGION, 2017–2025 ($MILLION)
TABLE 24. BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY REGION, 2017–2025 ($MILLION)
TABLE 25. BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2017–2025 ($MILLION)
TABLE 26. BRAIN MONITORING MARKET FOR OTHER DISEASES, BY REGION, 2017–2025 ($MILLION)
TABLE 27. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017–2025 ($MILLION)
TABLE 28. NORTH AMERICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 29. NORTH AMERICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 30. NORTH AMERICA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 31. NORTH AMERICA BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 32. U.S. BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 33. U.S. BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 34. U.S. BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 35. CANADA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 36. CANADA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 37. CANADA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 38. MEXICO BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 39. MEXICO BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 40. MEXICO BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 41. EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 42. EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 43. EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 44. EUROPE BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 45. GERMANY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 46. GERMANY BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 47. GERMANY BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 48. FRANCE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 49. FRANCE BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 50. FRANCE BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 51. UK BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 52. UK BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 53. UK BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 54. ITALY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55. ITALY BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 56. ITALY BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 57. SPAIN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 58. SPAIN BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 59. SPAIN BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 60. REST OF EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 61. REST OF EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 62. REST OF EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 63. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 65. ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 66. ASIA-PACIFIC BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 67. JAPAN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 68. JAPAN BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 69. JAPAN BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 70. CHINA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 71. CHINA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 72. CHINA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 73. AUSTRALIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 74. AUSTRALIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 75. AUSTRALIA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 76. INDIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 77. INDIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 78. INDIA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 82. LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 83. LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 84. LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 85. LAMEA BRAIN MONITORING MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 86. BRAZIL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 87. BRAZIL BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 88. BRAZIL BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 89. SAUDI ARABIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 90. SAUDI ARABIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 91. SAUDI ARABIA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 92. SOUTH AFRICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 93. SOUTH AFRICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 94. SOUTH AFRICA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 95. REST OF LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 96. REST OF LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017–2025 ($MILLION)
TABLE 97. REST OF LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 98. ADVANCED BRAIN MONITORING: COMPANY SNAPSHOT
TABLE 99. ADVANCED BRAIN MONITORING: BUSINESS AREA
TABLE 100. ADVANCED BRAIN MONITORING: PRODUCT PORTFOLIO
TABLE 101. CASMED: COMPANY SNAPSHOT
TABLE 102. CASMED: PRODUCT PORTFOLIO
TABLE 103. COMPUMEDICS: COMPANY SNAPSHOT
TABLE 104. COMPUMEDICS: PRODUCT PORTFOLIO
TABLE 105. GE: COMPANY SNAPSHOT
TABLE 106. GE: OPERATING SEGMENTS
TABLE 107. GE: PRODUCT PORTFOLIO
TABLE 108. PHILIPS: COMPANY SNAPSHOT
TABLE 109. PHILIPS: OPERATING SEGMENTS
TABLE 110. PHILIPS: PRODUCT PORTFOLIO
TABLE 111. MEDTRONIC: COMPANY SNAPSHOT
TABLE 112. MEDTRONIC: OPERATING SEGMENTS
TABLE 113. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 114. NATUS: COMPANY SNAPSHOT
TABLE 115. NATUS: PRODUCT PORTFOLIO
TABLE 116. NEURAL ANALYTICS: COMPANY SNAPSHOT
TABLE 117. NEURAL ANALYTICS: PRODUCT PORTFOLIO
TABLE 118. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 119. GSK: PRODUCT PORTFOLIO
TABLE 120. SEIMENS: COMPANY SNAPSHOT
TABLE 121. SEIMENS: PRODUCT SEGMENTS
TABLE 122. SEIMENS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. BRAIN MONITORING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. GLOBAL BRAIN MONITORING MARKET: DRIVERS AND RESTRAINTS
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INVASIVE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR NON-INVASIVE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. PERCENTAGE OF THE TOTAL POPULATION AGED 60 YEARS AND OVER, BY COUNTRY INCOME LEVEL, 2015 TO 2050
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER DISEASES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 29. CASMED: REVENUE, 2015–2017 ($MILLION)
FIGURE 30. CASMED: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 31. CASMED: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 32. COMPUMEDICS: REVENUE, 2016–2018 ($MILLION)
FIGURE 33. COMPUMEDICS: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. GE: NET SALES, 2015–2017 ($MILLION)
FIGURE 35. GE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. GE: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 37. PHILIPS: NET SALES, 2015–2017 ($MILLION)
FIGURE 38. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. PHILIPS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 40. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 41. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 42. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 43. NATUS: NET SALES, 2015–2017 ($MILLION)
FIGURE 44. NATUS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 45. NATUS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 46. NIHON KOHDEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. NIHON KOHDEN: REVENUE SHARE BY PRODUCT SEGMENT, 2018 (%)
FIGURE 48. NIHON KOHDEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. SEIMENS: NET SALES, 2015–2017 ($MILLION)
FIGURE 50. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 51. SEIMENS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 01. BRAIN MONITORING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. GLOBAL BRAIN MONITORING MARKET: DRIVERS AND RESTRAINTS
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INVASIVE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR NON-INVASIVE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. PERCENTAGE OF THE TOTAL POPULATION AGED 60 YEARS AND OVER, BY COUNTRY INCOME LEVEL, 2015 TO 2050
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR PARKINSON’S DISEASE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER DISEASES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 29. CASMED: REVENUE, 2015–2017 ($MILLION)
FIGURE 30. CASMED: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 31. CASMED: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 32. COMPUMEDICS: REVENUE, 2016–2018 ($MILLION)
FIGURE 33. COMPUMEDICS: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. GE: NET SALES, 2015–2017 ($MILLION)
FIGURE 35. GE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. GE: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 37. PHILIPS: NET SALES, 2015–2017 ($MILLION)
FIGURE 38. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. PHILIPS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 40. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 41. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 42. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 43. NATUS: NET SALES, 2015–2017 ($MILLION)
FIGURE 44. NATUS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 45. NATUS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 46. NIHON KOHDEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. NIHON KOHDEN: REVENUE SHARE BY PRODUCT SEGMENT, 2018 (%)
FIGURE 48. NIHON KOHDEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. SEIMENS: NET SALES, 2015–2017 ($MILLION)
FIGURE 50. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)
FIGURE 51. SEIMENS: REVENUE SHARE BY REGION, 2017 (%)
